Session I - Hip Fractures


Thurs., 10/4/12 Hip Fractures, PAPER #36, 4:29 pm OTA-2012

Delay to Surgery in Hip Fracture Patients: Effect on Mortality, Length of Stay and Postoperative Morbidity

Reshid Berber, MBBS; Christopher G. Moran, MD, FRCS;
Queen’s Medical Centre, Nottingham University Hospitals, Nottingham, United Kingdom

Purpose: This study was undertaken to determine whether a delay to surgery (>36 hours) affects mortality rate, length of stay, and postoperative complications following hip fracture surgery in elderly patients.

Methods: Data were collected by dedicated audit staff using a pro forma designed in accordance with the “Standardised Audit of Hip Fractures in Europe” (SAHFE). This was a prospective observational study; all patients (n = 7207) who were admitted and underwent surgery during a 10-year period from May 1999 to May 2009 have been considered. χ2 tests and independent-sample t tests were used for basic statistical analyses. Mortality data were analysed using Kaplan-Meier survival analysis and Cox regression analysis. P <0.05 was considered significant.

Results: The 30-day mortality was 9.5%. At 90 days, mortality was 18.9% and at 1 year it was 31.4%. In patients declared fit for surgery on admission (n = 5665), 30-day mortality was 7.5% in those operated on without delay, rising to 10.3% at over 4 days’ delay (P = 0.117). However, for those operated on after 5-day delay, 30-day mortality equaled 13.6% (P = 0.009). Those declared fit for surgery on admission stayed a total 14.5 days if operated within 36 hours, rising to 16 days with over 36 hours’ delay (P <0.001). An increase in the rate of urinary tract infection (3.9 vs 5.9%, P <0.001) was seen in patients delayed by over 36 hours. However, when considering all patients together, an increase in both urinary tract infection (3.9% vs 6.1%, P <0.001) and chest infections (7.9% vs 11.3%, P <0.001) was seen with over 36 hours’ delay to surgery.

Conclusion: The 30-day mortality following hip fracture surgery is 9.5%. Patients admitted without comorbidities have significantly increased mortality when surgery is delayed by over 5 days. A 36-hour delay to surgery significantly increases length of stay. Urinary tract infection was the only postoperative morbidity to rise with delay to surgery in fit patients.


Alphabetical Disclosure Listing (808K PDF)

• The FDA has not cleared this drug and/or medical device for the use described in this presentation   (i.e., the drug or medical device is being discussed for an “off label” use).  ◆FDA information not available at time of printing. Δ OTA Grant.